El equipo del Dr. Antonio Serrano, del Servicio de Inmunología del Hospital Universitario 12 de Octubre, ha descrito un nuevo marcador que permite explorar un novedoso mecanismo patogénico de los aPL.
Fuente: Diario Médico
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
You can also learn more about our Cookie policy and Data protection policy.